Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 527

1.

Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.

Itatsu K, Zen Y, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, Sato Y, Harada K, Sasaki M, Sasaki M, Sakamoto H, Nagino M, Nimura Y, Ohta T, Nakanuma Y.

Hum Pathol. 2008 May;39(5):710-9. doi: 10.1016/j.humpath.2007.09.016. Epub 2008 Mar 10.

PMID:
18329694
2.

Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.

Zhang C, Tu Z, Du S, Wang Y, Wang Q.

Pathol Oncol Res. 2010 Mar;16(1):47-53. doi: 10.1007/s12253-009-9186-5. Epub 2009 Jul 25.

PMID:
19629755
3.

Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.

Schwandner O, Schlamp A, Broll R, Bruch HP.

Int J Colorectal Dis. 2007 Feb;22(2):127-36. Epub 2006 Aug 2.

PMID:
16896992
5.

Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis.

Itatsu K, Zen Y, Ohira S, Ishikawa A, Sato Y, Harada K, Ikeda H, Sasaki M, Nimura Y, Nakanuma Y.

Liver Int. 2007 Nov;27(9):1174-84.

PMID:
17919228
6.

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C.

World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.

PMID:
19294467
7.

CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.

Nishihara Y, Aishima S, Hayashi A, Iguchi T, Fujita N, Taketomi A, Honda H, Tsuneyoshi M.

Histopathology. 2009 Oct;55(4):423-31. doi: 10.1111/j.1365-2559.2009.03398.x.

PMID:
19817893
8.

Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases.

Hoang MP, Murakata LA, Katabi N, Henson DE, Albores-Saavedra J.

Mod Pathol. 2002 Dec;15(12):1251-8.

9.

The ratio of MMP-2 to TIMP-2 in hilar cholangiocarcinoma: a semi-quantitative study.

Xiao M, Zhou NX, Huang ZQ, Lu YL, Chen LH, Wang DJ, Chang WL.

Hepatobiliary Pancreat Dis Int. 2004 Nov;3(4):599-602.

10.

Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.

Yamaguchi K, Chijiiwa K, Saiki S, Shimizu S, Takashima M, Tanaka M.

Hepatogastroenterology. 1997 Sep-Oct;44(17):1256-61.

PMID:
9356836
11.

The concept of perihilar cholangiocarcinoma is valid.

Ebata T, Kamiya J, Nishio H, Nagasaka T, Nimura Y, Nagino M.

Br J Surg. 2009 Aug;96(8):926-34. doi: 10.1002/bjs.6655.

PMID:
19591162
12.

Clinicopathologic study of cholangiocarcinoma with superficial spread.

Igami T, Nagino M, Oda K, Nishio H, Ebata T, Yokoyama Y, Shimoyama Y.

Ann Surg. 2009 Feb;249(2):296-302. doi: 10.1097/SLA.0b013e318190a647.

PMID:
19212185
13.

Expression of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in intraductal and nonintraductal growth type of cholangiocarcinoma.

Jo Chae K, Rha SY, Oh BK, Koo JS, Kim YJ, Choi J, Park C, Park YN.

Am J Gastroenterol. 2004 Jan;99(1):68-75.

PMID:
14687144
14.

Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma.

Hirashita T, Iwashita Y, Ohta M, Komori Y, Eguchi H, Yada K, Kitano S.

J Gastrointest Surg. 2012 Apr;16(4):842-8. doi: 10.1007/s11605-011-1813-2. Epub 2012 Jan 13.

15.

L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma.

Li S, Jo YS, Lee JH, Min JK, Lee ES, Park T, Kim JM, Hong HJ.

Clin Cancer Res. 2009 Dec 1;15(23):7345-51. doi: 10.1158/1078-0432.CCR-09-0959. Epub 2009 Nov 17.

16.

Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).

Schmitz KJ, Lang H, Kaiser G, Wohlschlaeger J, Sotiropoulos GC, Baba HA, Jasani B, Schmid KW.

Hum Pathol. 2009 Dec;40(12):1706-14. doi: 10.1016/j.humpath.2009.01.026. Epub 2009 Aug 14.

PMID:
19683330
17.

Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.

Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, Sugai T, Wakabayashi G, Ohkohchi N.

World J Surg. 2007 Sep;31(9):1788-96. Epub 2007 Jul 25.

PMID:
17647056
18.

The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.

Singal AG, Rakoski MO, Salgia R, Pelletier S, Welling TH, Fontana RJ, Lok AS, Marrero JA.

Aliment Pharmacol Ther. 2010 Mar;31(6):625-33. doi: 10.1111/j.1365-2036.2009.04218.x. Epub 2009 Dec 10.

19.
20.

Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.

Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Iguchi T, Taketomi A, Maehara Y, Tsuneyoshi M.

Hum Pathol. 2007 Dec;38(12):1819-25. Epub 2007 Sep 14.

PMID:
17854859

Supplemental Content

Support Center